6.
Baksh R, Ritchie C, Terrera G, Norton J, Raymont V, Ritchie K
. The association between anxiety disorders and hippocampal volume in older adults. Psychol Aging. 2021; 36(2):288-297.
DOI: 10.1037/pag0000597.
View
7.
Barros M, Tomaz C
. Non-human primate models for investigating fear and anxiety. Neurosci Biobehav Rev. 2002; 26(2):187-201.
DOI: 10.1016/s0149-7634(01)00064-1.
View
8.
Belujon P, Grace A
. Dopamine System Dysregulation in Major Depressive Disorders. Int J Neuropsychopharmacol. 2017; 20(12):1036-1046.
PMC: 5716179.
DOI: 10.1093/ijnp/pyx056.
View
9.
Bentley K, Franklin J, Ribeiro J, Kleiman E, Fox K, Nock M
. Anxiety and its disorders as risk factors for suicidal thoughts and behaviors: A meta-analytic review. Clin Psychol Rev. 2015; 43:30-46.
PMC: 4771521.
DOI: 10.1016/j.cpr.2015.11.008.
View
10.
Berger M, Gray J, Roth B
. The expanded biology of serotonin. Annu Rev Med. 2009; 60:355-66.
PMC: 5864293.
DOI: 10.1146/annurev.med.60.042307.110802.
View
11.
Boldrini M, Butt T, Santiago A, Tamir H, Dwork A, Rosoklija G
. Benzodiazepines and the potential trophic effect of antidepressants on dentate gyrus cells in mood disorders. Int J Neuropsychopharmacol. 2014; 17(12):1923-33.
PMC: 4374628.
DOI: 10.1017/S1461145714000844.
View
12.
Boyle M, Kolber B, Vogt S, Wozniak D, Muglia L
. Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness. J Neurosci. 2006; 26(7):1971-8.
PMC: 6674945.
DOI: 10.1523/JNEUROSCI.2173-05.2006.
View
13.
Boyle N, Lawton C, Dye L
. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress-A Systematic Review. Nutrients. 2017; 9(5).
PMC: 5452159.
DOI: 10.3390/nu9050429.
View
14.
Brennan B, Admon R, Perriello C, LaFlamme E, Athey A, Pizzagalli D
. Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram. Psychiatry Res Neuroimaging. 2017; 269:9-16.
PMC: 5642118.
DOI: 10.1016/j.pscychresns.2017.08.009.
View
15.
Bromberg-Martin E, Matsumoto M, Hikosaka O
. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron. 2010; 68(5):815-34.
PMC: 3032992.
DOI: 10.1016/j.neuron.2010.11.022.
View
16.
Brueckle M, Thomas E, Seide S, Pilz M, Gonzalez-Gonzalez A, Dinh T
. Amitriptyline's anticholinergic adverse drug reactions-A systematic multiple-indication review and meta-analysis. PLoS One. 2023; 18(4):e0284168.
PMC: 10075391.
DOI: 10.1371/journal.pone.0284168.
View
17.
Butler M, Bastiaanssen T, Long-Smith C, Morkl S, Berding K, Ritz N
. The gut microbiome in social anxiety disorder: evidence of altered composition and function. Transl Psychiatry. 2023; 13(1):95.
PMC: 10027687.
DOI: 10.1038/s41398-023-02325-5.
View
18.
Byeon J, Moon J, Je S, Park S, Kim J
. Quantitative electroencephalographic biomarker of pharmacological treatment response in patients with anxiety disorder: a retrospective study. Sci Rep. 2023; 13(1):3802.
PMC: 9992385.
DOI: 10.1038/s41598-023-30994-1.
View
19.
Califf R
. Biomarker definitions and their applications. Exp Biol Med (Maywood). 2018; 243(3):213-221.
PMC: 5813875.
DOI: 10.1177/1535370217750088.
View
20.
Cameron H, Schoenfeld T
. Behavioral and structural adaptations to stress. Front Neuroendocrinol. 2018; 49:106-113.
PMC: 5963997.
DOI: 10.1016/j.yfrne.2018.02.002.
View